Lipoperoxidation and hemodialysis

Metabolism: Clinical and Experimental

Volumn 57, Issue 10, 2008, Pages 1369-1374

  Ramos, Rosa ^a   Martínez Castelao, Alberto ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; COPPER ION; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID PEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; PLACEBO; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEART PROTECTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAINTENANCE THERAPY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UREMIA; VITAMIN SUPPLEMENTATION;

EID: 51849150860     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.05.004     Document Type: Article

References (31)

1. Loughrey C.M., Young I., McEneny J., McDowell F.W., McMaster C., McNamee P., et al. Oxidation of low-density lipoprotein in patients on regular haemodialysis. Atherosclerosis 110 (1994) 185-193
2. Raine A.E.G., MacMahon S., Selwood N.H., Wing A.J., and Brunner F.P. Mortality from myocardial infarction in patients on renal replacement therapy. Nephrol Dial Transplant 6 (1991) 902
3. Galli F., Canestrari F., and Bellomo G. Pathophysiology of the oxidative stress and its implication in uremia and dialysis. Contrib Nephrol 127 (1999) 1-31
4. Descombes E., Hanck A., and Fellay G. Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 43 (1993) 1319-1328
5. Cristol J.P., Bosc J., Badiou S., Leblanc M., Lorrho R., Descomps B., et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 12 (1997) 2312-2317
6. Boaz M., Smetana S., Weinstein T., et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356 (2000) 1213-1218
7. Deicher R., and Hörl W. Vitamin C in chronic kidney disease and hemodialysis patients. Kidney Blood Press Res 26 (2003) 100-106
8. Sullivan J.F., and Eisenstein A. Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am J Clin Nutr 23 (1970) 1339-1346
9. Pönka A., and Kuhlback B. Serum ascorbic acid in patients undergoing chronic hemodialysis. Acta Med Scand 213 (1983) 305-307
10. Fumeron C., Nguyen-Khoa T., Saltiel C., Kebede M., Buisson C., Drüeke T.B., et al. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant 20 (2005) 1874-1879
11. Shulz T.H., Schiffl H., Scheithe R., Hrboticky N., and Lorenz R. Preserved antioxidative defence of lipoproteins in renal failure and during hemodialysis. Am J Kidney Dis XXV (1995) 564-571
12. Himmelfarb J., Stenvinkel P., Alp Ikizler T., and Hakim R.M. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62 (2002) 1524-1538
13. Wratten M.L., Tetta C., Ursini F., and Sevanian A. Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int 58 (2000) s126-s132
14. Toborek M., Wasik T., Drózdz M., Klin M., Magner-Wróbel K., and Kopieczna-Grzebieinak E. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 41 (1992) 1229-1232
15. Hugue V., Kandoussi M., Parra H.J., Dracon M., Fruchart J.C., Tacquet A., and Cachera C. Alteration of the lipid and apolipoprotein contents of lipoprotein (a) in haemodialysis patients. Nephrol Dial Transplant 11 (1996) 825-829
16. Attman P.O., Samuelsson O., and Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 21 (1993) 573-591
17. Ramos R., Gómez-Geriqué N., and Martinez-Castelao A. Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation. Nefrologia XXV (2005) 178-184
18. Okubo K., Ikewaki K., Sakai S., et al. Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study. J Am Soc Nephrol 15 (2004) 1008-1015
19. Nishizawa Y., Shoji T., Kakiya R., Tsujimoto Y., Tabata T., Ishimura E., et al. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl 63 (2003) 2345-2346
20. Cristol J.P., Canaud B., Rabesandratana H., Gaillard I., Serre A., and Mion C. Enhancement of reactive oxygen species production and cell surface markers expression during hemodialysis. Nephrol Dial Transplant 9 (1994) 389-394
21. Peuchant E., Carbonneau M., Dubourg L., Thomas M.J., Perromat A., Vallot C., et al. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamin A, E, and iron status. Free Rad Biol Med 16 (1994) 339
22. Maher E.R., Wickens D., Griffin J.F., Kyle P., and Curtis J.R. Increased free-radical activity during haemodialysis?. Nephrol Dial Transplant 2 (1987) 169-171
23. Fillit H., Elion E., Sullivan J., Sherman R., and Zabriskie J.B. Thiobarbituric acid reactive material in uremic blood. Nephron 29 (1981) 40-43
24. Dasgupta A., Hussain S., and Ahmad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 60 (1992) 56-59
25. Richard M., Arnaud J., Jurkovitz C., et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57 (1991) 10-15
26. Wen Y., Cooke T., and Feely J. The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation. Br J Clin Pharmacol 44 (1997) 94-97
27. Esterbauer H., Gebicki J., Puhl H., and Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification. Free Rad Biol Med 13 (1992) 341-390
28. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Rad Res 25 (1996) 439-454
29. Naidoo D., and Lux O. The effect of vitamin C and E supplementation on lipid and urate oxidation products in plasma. Nutr Res 18 (1998) 953-961
30. Hodis H.N., Mack W., LaBree L., et al. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106 (2002) 1453-1459
31. Keven K., Kutlay S., Nergizoglu G., and Erturk S. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Am J Kidney Dis 41 (2003) 1233-1239